tranexamic acid has been researched along with Angiogenesis, Pathologic in 8 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TA) has been widely used in the treatment of these severe bleeds but with no properly designed trial." | 6.79 | Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. ( Boutitie, F; Capitaine, AL; Dupuis-Girod, S; Gaillard, S; Gueyffier, F; Hatron, PY; Kaminsky, P; Manfredi, G; Morinière, S; Plauchu, H; Rivière, S; Roy, P, 2014) |
| "Rosacea is a chronic inflammatory cutaneous disease characterized by immune system anomalies and vascular hyperreactivity." | 5.51 | Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. ( Deng, Z; Li, J; Li, Y; Tang, Y; Wang, B; Xie, H; Xu, S; Yuan, X; Zhang, Y; Zhao, Z; Zuo, Z, 2019) |
| " pentoxifylline (Px) (which also were found to release PgI2 and t-PA) inhibited human tumor implant induced angiogenesis and reduced spontaneous metastases in 3 transplantable murine tumors (Furth-Columbia Wilms' tumor in Furth-Wistar rats, C-1300 neuroblastoma in A/J mice and HM-Kim mammary carcinoma in Wistar rats) but not in the NIH adenocarcinoma in Balb/c mice." | 3.68 | Studies on tumor induced angiogenesis. ( Ambrus, CM; Ambrus, JL; Forgach, P; Halpern, J; Niswander, P; Sayyid, S; Stadler, S; Toumbis, C, 1992) |
| "Tranexamic acid (TA) has been widely used in the treatment of these severe bleeds but with no properly designed trial." | 2.79 | Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. ( Boutitie, F; Capitaine, AL; Dupuis-Girod, S; Gaillard, S; Gueyffier, F; Hatron, PY; Kaminsky, P; Manfredi, G; Morinière, S; Plauchu, H; Rivière, S; Roy, P, 2014) |
| "Melasma is a common acquired disorder of hyperpigmentation, classically manifesting as symmetric brown patches on the face." | 2.66 | The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence. ( Austin, E; Jagdeo, J; Masub, N; Nguyen, JK, 2020) |
| "Rosacea is a chronic inflammatory cutaneous disease characterized by immune system anomalies and vascular hyperreactivity." | 1.51 | Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis. ( Deng, Z; Li, J; Li, Y; Tang, Y; Wang, B; Xie, H; Xu, S; Yuan, X; Zhang, Y; Zhao, Z; Zuo, Z, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Masub, N | 1 |
| Nguyen, JK | 1 |
| Austin, E | 1 |
| Jagdeo, J | 1 |
| Li, Y | 1 |
| Xie, H | 1 |
| Deng, Z | 1 |
| Wang, B | 1 |
| Tang, Y | 1 |
| Zhao, Z | 1 |
| Yuan, X | 1 |
| Zuo, Z | 1 |
| Xu, S | 1 |
| Zhang, Y | 1 |
| Li, J | 1 |
| Erdogan, U | 1 |
| Tanik, C | 1 |
| Tanriverdi, O | 1 |
| Gunaldi, O | 1 |
| Yilmaz, I | 1 |
| Arslanhan, A | 1 |
| Ofluoglu, AE | 1 |
| Gaillard, S | 1 |
| Dupuis-Girod, S | 1 |
| Boutitie, F | 1 |
| Rivière, S | 1 |
| Morinière, S | 1 |
| Hatron, PY | 1 |
| Manfredi, G | 1 |
| Kaminsky, P | 1 |
| Capitaine, AL | 1 |
| Roy, P | 1 |
| Gueyffier, F | 1 |
| Plauchu, H | 1 |
| Gupta, D | 1 |
| Mishra, S | 1 |
| Bhatnagar, S | 1 |
| Jain, V | 1 |
| Gamanagatti, S | 1 |
| Sundbeck, A | 2 |
| Myrhage, R | 1 |
| Peterson, HI | 2 |
| Karlsson, L | 1 |
| Lilja, J | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Forgach, P | 1 |
| Stadler, S | 1 |
| Halpern, J | 1 |
| Sayyid, S | 1 |
| Niswander, P | 1 |
| Toumbis, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma. A Double-blind, Placebo-controlled, Multicentre, Randomized Controlled Clinical Trial[NCT03582293] | Phase 3 | 140 participants (Anticipated) | Interventional | 2018-06-19 | Recruiting | ||
| ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome. Beneficial or Iatrogenic Effects.[NCT00355108] | Phase 3 | 170 participants (Actual) | Interventional | 2006-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence.
Topics: Administration, Cutaneous; Administration, Oral; Angiogenesis Inhibitors; Dermoscopy; Humans; Lasers | 2020 |
1 trial available for tranexamic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Topics: Adult; Aged; Antifibrinolytic Agents; Cross-Over Studies; Double-Blind Method; Epistaxis; Europe; Fe | 2014 |
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Topics: Adult; Aged; Antifibrinolytic Agents; Cross-Over Studies; Double-Blind Method; Epistaxis; Europe; Fe | 2014 |
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Topics: Adult; Aged; Antifibrinolytic Agents; Cross-Over Studies; Double-Blind Method; Epistaxis; Europe; Fe | 2014 |
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Topics: Adult; Aged; Antifibrinolytic Agents; Cross-Over Studies; Double-Blind Method; Epistaxis; Europe; Fe | 2014 |
6 other studies available for tranexamic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis.
Topics: Animals; Antimicrobial Cationic Peptides; Cathelicidins; Cell Line; Human Umbilical Vein Endothelial | 2019 |
Immunohistochemical Grading of Epidural Fibrosis with CD105 Antibody.
Topics: Animals; Antibodies, Monoclonal; Antifibrinolytic Agents; Biomarkers; Endoglin; Epidural Space; Fibr | 2019 |
Trial of angioembolization of advanced stage tumors feeding arteries exemplifying aggressive and active interventional palliation.
Topics: Aminocaproates; Antifibrinolytic Agents; Carcinoma, Renal Cell; Embolization, Therapeutic; Humans; K | 2008 |
Influence of tranexamic acid on tumour vascularization. An experimental microangiographic study.
Topics: Angiography; Animals; Cyclohexanecarboxylic Acids; Muscles; Neoplasm Transplantation; Neovasculariza | 1981 |
Inhibition of tumour vascularization by tranexamic acid. Experimental studies on possible mechanisms.
Topics: Angiography; Animals; Cyclohexanecarboxylic Acids; Indomethacin; Microscopy, Electron; Muscles; Neop | 1981 |
Studies on tumor induced angiogenesis.
Topics: Adenocarcinoma; Aminocaproic Acid; Animals; Cornea; Ditiocarb; Humans; Kidney Neoplasms; Macaca; Mam | 1992 |